Study S000178

A Study of ALT-801 in Patients With Relapsed or Refractory Multiple Myeloma

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT01670994
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE1; PHASE2
Masking: NONE
Status: TERMINATED
Enrollment: 6
Start: 2012-08-14
Primary completion: 2015-09-09
Lead sponsor: Altor BioScience
Conditions: Relapsed or Refractory Multiple Myeloma
Interventions: BIOLOGICAL:ALT-801
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Number of Participants With Treatment-Related Adverse Events [7 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.